Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- befree-2016 importedOn "2016-02-19" NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_assertion wasGeneratedBy ECO_0000203 NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_assertion wasDerivedFrom befree-2016 NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_assertion SIO_000772 14633710 NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_assertion evidence source_evidence_literature NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.
- NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_assertion description "[Antitumor effects of a soluble form dominant negative of the type I insulin-like growth factor receptor (IGF-IR) designated as 486/STOP were evaluated in CaOV-3 human ovarian cancer cells by establishing stable transformants overexpressing 486/STOP and by administration of 486/STOP recombinant protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421700.RAXxBldou5AVYtZ_6gIyHRiSkzhwAI3ZX9gvscyOUhUrE130_provenance.